Pharmacogenomics of statins: understanding susceptibility to adverse effects

Pharmacogenomics of statins: understanding susceptibility to adverse effects

Joseph P Kitzmiller,1 Eduard B Mikulik,1 Anees M Dauki,2 Chandrama Murkherjee,1 Jasmine A Luzum3 1Department of Biological Chemistry and Pharmacology, College of Medicine, 2College of Pharmacy, The Ohio State University, Columbus, OH, 3Department of Clinical Pharmacy, University of Michigan College...

Full description

Bibliographic Details
Main Authors: Kitzmiller JP, Mikulik EB, Dauki AM, Mukherjee C, Luzum JA
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
statin
myopathy
adverse effects
lipids
muscle toxicity
Online Access:https://www.dovepress.com/pharmacogenomics-of-statins-understanding-susceptibility-to-adverse-ef-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/pharmacogenomics-of-statins-understanding-susceptibility-to-adverse-ef-peer-reviewed-article-PGPM

Similar Items